JYANT Technologies, Inc. is an early stage product development company based in Marietta, GA. Leveraging a strong intellectual property position, JYANT is dedicated to developing and delivering disruptive technologies to patients, with a unique focus on unmet medical needs in oncology and inflammatory diseases.
With a therapeutic product pipeline that includes innovative solutions for a range of indications such as IBD, RA, solid tumors, and MS, JYANT utilizes patented anti-chemokine and anti-chemokine receptor antibodies, as well as nanotechnology applications, to provide ground-breaking diagnostic and treatment options. Through strategic alliances, JYANT aims to rapidly translate their development programs and address the pressing medical challenges of today.
Generated from the website